Insider Transactions in Q2 2025 at Aura Biosciences, Inc. (AURA)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 17
2025
|
Antony C. Mattessich |
BUY
Grant, award, or other acquisition
|
Direct |
13,000
+35.62%
|
-
|
Jun 17
2025
|
David Michael Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
13,000
+6.76%
|
-
|
Jun 17
2025
|
Sapna Srivastava |
BUY
Grant, award, or other acquisition
|
Direct |
13,000
+35.62%
|
-
|
Jun 02
2025
|
Pinos Elisabet De Los |
SELL
Payment of exercise price or tax liability
|
Direct |
9,948
-2.02%
|
$59,688
$6.16 P/Share
|
Jun 02
2025
|
Pinos Elisabet De Los |
BUY
Exercise of conversion of derivative security
|
Direct |
10,948
+2.17%
|
$54,740
$5.07 P/Share
|
Jun 02
2025
|
Anthony S Gibney |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+42.02%
|
-
|
May 16
2025
|
David Michael Johnson |
BUY
Open market or private purchase
|
Direct |
20,000
+10.74%
|
$80,000
$4.9 P/Share
|
May 16
2025
|
Anthony S Gibney |
SELL
Open market or private sale
|
Direct |
1,519
-2.6%
|
$7,595
$5.15 P/Share
|
May 16
2025
|
Anthony S Gibney |
BUY
Open market or private purchase
|
Direct |
50,000
+46.1%
|
$200,000
$4.9 P/Share
|
Apr 16
2025
|
Conor Kilroy |
SELL
Open market or private sale
|
Direct |
7,162
-3.84%
|
$35,810
$5.49 P/Share
|
Apr 16
2025
|
Amy Elazzouzi Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
897
-1.09%
|
$4,485
$5.49 P/Share
|